Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,722 | 53,506 | 60,048 | 12,442 | 13,444 |
| TOTAL | $46,149 | $54,090 | $60,403 | $12,999 | $13,750 |
| Non-Current Assets | |||||
| PPE Net | 2,700 | 1,752 | 1,228 | 1,102 | 1,114 |
| Other Non-Current Assets | 130 | 130 | 130 | 130 | 130 |
| TOTAL | $2,830 | $1,882 | $1,358 | $1,232 | $1,244 |
| Total Assets | $48,979 | $55,972 | $61,761 | $14,231 | $14,994 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,825 | 1,912 | 1,758 | 605 | 890 |
| Accrued Expenses | 3,149 | 1,750 | 2,121 | 2,272 | 2,328 |
| TOTAL | $7,596 | $4,154 | $4,244 | $3,116 | $3,361 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,596 | $4,154 | $4,244 | $3,116 | $3,361 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,281 | 15,281 | 15,110 | 15,110 | 10,002 |
| Common Shares | 3,058 | 152 | 3,024 | 2,004 | 2,002 |
| Retained earnings | -196,540 | -183,587 | -175,850 | -169,729 | -165,160 |
| TOTAL | $41,383 | $51,818 | $57,517 | $11,115 | $11,633 |
| Total Liabilities And Equity | $48,979 | $55,972 | $61,761 | $14,231 | $14,994 |